Circulating metabolomic profile indicates mitochondrial dysfunction in HIV-dyslipidemia
A. rull aixa(Institut de Recerca Biomèdica Catalunya Sud), Francesc Vidal(Institut de Recerca Biomèdica Catalunya Sud), Raúl Beltrán‐Debón(Institut de Recerca Biomèdica Catalunya Sud), Esther Rodríguez‐Gallego(Institut de Recerca Biomèdica Catalunya Sud), Verònica Alba, Félix Gutiérrez(Universitat de Miguel Hernández d'Elx), S. Ferrando-MartíneZ, Yolanda M. Pacheco(Instituto de Biomedicina de Sevilla), Josep Gómez(Hospital Universitari Joan XXIII de Tarragona), Peré Domingo(Hospital de Sant Pau), Consuelo Viladés(Hospital Universitario Fundación Jiménez Díaz), Sergio Veloso(Hospital Terrassa), Miguel López-Dupla, M. Leal(Instituto de Biomedicina de Sevilla), Montserrat Vargas(Hospital Universitari Joan XXIII de Tarragona), Alfonso J. Castellano(Institut de Recerca Biomèdica Catalunya Sud), Joaquim Peraire(Instituto de Salud Carlos III), Ezequiel Ruíz-Mateos(Apple (Israel))
Cited by 0
Related Papers
Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
|JAMA|2021|728
Altered metabolism of gut microbiota contributes to chronic immune activation in HIV-infected individuals
|Mucosal Immunology|2014|332
Follicular CD8 T cells accumulate in HIV infection and can kill infected cells in vitro via bispecific antibodies
|Science Translational Medicine|2017|169